Viking Therapeutics Ownership | Who Owns Viking Therapeutics?


OverviewForecastFinancialsChartTranscripts

Viking Therapeutics Ownership Summary


Viking Therapeutics is owned by 62.32% institutional investors, 2.17% insiders, and 35.51% retail investors. Vanguard group is the largest institutional shareholder, holding 8.92% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.

VKTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockViking Therapeutics62.32%2.17%35.51%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group10.00M8.92%$262.78M
Blackrock6.03M5.82%$319.45M
Fmr5.79M5.16%$152.16M
Blackrock funding, inc. /de5.60M4.99%$147.07M
State street4.51M4.03%$118.62M
Morgan stanley3.73M3.33%$98.00M
Jpmorgan chase2.58M2.30%$67.73M
Ameriprise financial2.09M1.87%$55.00B
Two sigma investments, lp2.09M1.86%$54.81M
Pictet asset management sa1.92M1.71%$50.80M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Profit investment management76.55K2.53%$2.01M
First washington266.84K1.88%$7.01M
Kintayl capital lp100.19K1.62%$2.63M
Toms capital investment management lp763.60K1.52%$40.48M
Diadema partners lp193.69K1.30%$5.09M
Maso capital partners25.00K1.08%$657.00K
Blackbarn capital partners lp500.00K0.94%$13.14M
Tang capital management870.00K0.88%$22.86M
Quantum private wealth105.02K0.81%$2.76M
Persistent asset partners44.58K0.81%$1.17M

Top Buyers

HolderShares% AssetsChange
Norges bank1.28M0.01%1.28M
Balyasny asset management860.45K0.05%860.45K
Two sigma investments, lp2.09M0.08%771.70K
Toms capital investment management lp763.60K1.52%763.60K
State street4.51M0.00%738.14K

Top Sellers

HolderShares% AssetsChange
Fmr5.79M0.01%-4.03M
Avoro capital advisors---3.59M
Blackrock6.03M0.01%-2.25M
Massachusetts financial services co /ma/---1.36M
Perpetual---1.27M

New Positions

HolderShares% AssetsChangeValue
Norges bank1.28M0.01%1.28M$51.46M
Toms capital investment management lp763.60K1.52%763.60K$40.48M
Baker bros. advisors lp366.08K0.07%366.08K$9.62M
Bridgewater associates, lp123.49K0.01%123.49K$3.25M
Bellevue group76.08K0.04%76.08K$2.00M

Sold Out

HolderChange
True wealth design-1.00
Twin peaks wealth advisors-2.00
Concord wealth partners-5.00
Capital advisors-8.00
Total investment management-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025387-6.52%69,883,492-2.34%621.53%194-15.28%101-5.61%
Jun 30, 20254131.72%76,058,9770.09%671.48%224-0.44%1083.85%
Mar 31, 2025402-10.67%76,083,022-7.14%671.24%220-5.98%105-16.67%
Dec 31, 2024414-10.78%75,828,361-8.31%681.23%216-21.17%1146.54%
Sep 30, 20244606.48%82,562,3852.80%741.41%2728.80%106-4.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O5.10M4.61%70.32K
Vanguard Total Stock Mkt Idx Inv3.38M3.00%-72.21K
Vanguard US Total Market Shares ETF3.32M2.96%2.50K
Vanguard Small Cap Index2.59M2.30%-17.31K
SPDR® S&P Biotech ETF1.92M1.71%4.29K
Vanguard Small Cap Growth Index Inv1.44M1.28%-556.00
Vanguard Institutional Extnd Mkt Idx Tr1.21M1.07%-529.99K
Fidelity Select Health Care1.18M1.05%-160.00K
Fidelity Growth Compy Commingled Pl S1.14M1.01%-454.62K
JPM US Mid Cap Growth-Composite1.09M0.97%-55.90K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 28, 2025Mancini Marianna Chief Operating OfficerSell$216.49K
Oct 27, 2025Rowland Charles A Jr-Sell$2.13M
Oct 28, 2025Lian Brian President & CEOSell$1.36M
Oct 28, 2025ZANTE GREG Chief Financial OfficerSell$216.48K
Jul 03, 2025Lian Brian President & CEOSell$747.63K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q3-3
2025 Q2--
2025 Q116
2024 Q4-11

VKTX Ownership FAQ


Who Owns Viking Therapeutics?

Viking Therapeutics shareholders are primarily institutional investors at 62.32%, followed by 2.17% insiders and 35.51% retail investors. The average institutional ownership in Viking Therapeutics's industry, Biotech Stocks , is 45.22%, which Viking Therapeutics exceeds.

Who owns the most shares of Viking Therapeutics?

Viking Therapeutics’s largest shareholders are Vanguard group (10M shares, 8.92%), Blackrock (6.03M shares, 5.82%), and Fmr (5.79M shares, 5.16%). Together, they hold 19.91% of Viking Therapeutics’s total shares outstanding.

Does Blackrock own Viking Therapeutics?

Yes, BlackRock owns 5.82% of Viking Therapeutics, totaling 6.03M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 319.45M$. In the last quarter, BlackRock decreased its holdings by -2.248M shares, a -27.17% change.

Who is Viking Therapeutics’s biggest shareholder by percentage of total assets invested?

Profit investment management is Viking Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.53% of its assets in 76.55K Viking Therapeutics shares, valued at 2.01M$.

Who is the top mutual fund holder of Viking Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Viking Therapeutics shares, with 4.61% of its total shares outstanding invested in 5.1M Viking Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools